Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 54 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10004687

    Liposomal curcumin for treatment of diseases

    The Board of Regents of the University of Texas System · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  2. US 10000523

    β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

    Atea Pharmaceuticals, Inc. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  3. US 10001483

    Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  4. US 10000753

    Age-related macular degeneration treatment

    Benitec Biopharma Limited · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  5. US 10000525

    Non-hormonal steroid modulators of NF-κB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted
  6. US 9993449

    (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid, and related compounds as GABA aminotransferase inactivators for the treatment of epilepsy, addiction and hepatocellular carcinoma

    Northwestern University · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  7. US 9993660

    Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections

    The United States of America as represented by the Secretary of Navy · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  8. US 9994901

    Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  9. US 9993481

    Methods and compositions for the treatment of metabolic disorders

    BIOMARIN PHARMACEUTICAL INC. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted
  10. US 9988447

    Treatment of diabetes

    XBIOTECH INC. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  11. US 9987242

    Treatment of Levodopa-induced Dyskinesias

    Northwestern University · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  12. US 9987326

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jun 5, 2018 · Expires May 31, 2038

    granted
  13. US 9981968

    Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders

    Northwestern University · Granted May 29, 2018 · Expires May 24, 2038

    granted
  14. US 9975944

    Synthetic peptides for the treatment of autoimmune diseases

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  15. US 9977875

    Systems and methods of managing treatment of a chronic condition by symptom tracking

    Corcept Therapeutics Incorporated · Granted May 22, 2018 · Expires May 17, 2038

    granted
  16. US 9974802

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted May 22, 2018 · Expires May 17, 2038

    granted
  17. US 9968586

    Mast cell stabilizers treatment for systemic disorders

    Patara Pharma, LLC · Granted May 15, 2018 · Expires May 10, 2038

    granted
  18. US 9968631

    Method for treatment of pulmonary fibrosis

    GALECTIN THERAPEUTICS, INC. · Granted May 15, 2018 · Expires May 10, 2038

    granted
  19. US 9968642

    Compositions and methods for treatment of pain

    Northwestern University · Granted May 15, 2018 · Expires May 10, 2038

    granted
  20. US 9962370

    Methods of treatment associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted May 8, 2018 · Expires May 3, 2038

    granted
  21. US 9963715

    Methods and compositions for treatment of a genetic condition

    Sangamo Therapeutics, Inc. · Granted May 8, 2018 · Expires May 3, 2038

    granted
  22. US 9962363

    Mast cell stabilizers treatment for systemic disorders

    Patara Pharma, LLC · Granted May 8, 2018 · Expires May 3, 2038

    granted
  23. US 9957329

    Factor XII inhibitors for the treatment of neurological inflammatory disorders

    Julius-Maximilians-Universitat Wurzburg · Granted May 1, 2018 · Expires Apr 26, 2038

    granted
  24. US 9956282

    Bacterial compositions and methods of use thereof for treatment of immune system disorders

    Seres Therapeutics, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted